Engineering Multifunctional Hydrogel With Osteogenic Capacity for Critical-Size Segmental Bone Defect Repair

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Critical-size segmental bone defects pose significant clinical challenges.
• Developing effective bone graft substitutes with osteoinductive properties is crucial for bone repair.
• Dynamic supramolecular assembly offers a versatile approach for creating advanced biomaterials.

Purpose of the Study:

• To design and characterize a novel biocompatible hydrogel for bone regeneration.
• To evaluate the in vitro and in vivo efficacy of a tetraethyl orthosilicate (TEOS)-containing hydrogel in promoting bone healing.
• To investigate the osteogenic potential of the hydrogel on bone marrow mesenchymal stem cells (BMSCs).

Main Methods:

• Hydrogel synthesis via dynamic supramolecular assembly of polyvinyl alcohol (PVA), sodium tetraborate (Na₂B₄O₇), and tetraethyl orthosilicate (TEOS).
• Characterization using rheological analysis, swelling ratio, degradation studies, and scanning electron microscopy (SEM).
• In vitro evaluation of biocompatibility and osteogenic differentiation of BMSCs. In vivo assessment in rabbit segmental bone defect models.

Main Results:

• The TEOS-hydrogel exhibited self-healing, low swelling, degradability, and good biocompatibility.
• In vitro studies showed the hydrogel upregulated key osteogenic markers (Runx-2, Col-1, OCN, OPN) in BMSCs.
• In vivo application in rabbit models accelerated bone regeneration, restored bone continuity, and recanalized the medullary cavity.

Conclusions:

• The developed TEOS-hydrogel demonstrates significant potential as a bone graft substitute for treating critical-size segmental bone defects.
• The hydrogel's ability to promote osteogenic differentiation and accelerate bone repair highlights its therapeutic value.
• This supramolecular hydrogel represents a promising strategy for enhancing bone healing and restoring bone integrity.